Patients with a rare, deadly disease that mostly affects young women felt a dramatic reduction in breathlessness using an approved drug, according to study results published online in The Journal of Heart and Lung Transplantation. The treatment, continuous intravenous (IV) treprostinil, has...
Patients with a rare, deadly disease that mostly affects young women felt a dramatic reduction in breathlessness using an approved drug, according to study results published online in The Journal of Heart and Lung Transplantation. The treatment, continuous intravenous (IV) treprostinil, has...